Edaravone and Dexborneol for chemo-related memory loss
Treatments studied
Part of Brain & nervous system, Cancer clinical trials.
This trial tests if a sublingual tablet can help people who have memory and thinking problems related to chemotherapy. If you have had certain types of chemotherapy and now notice trouble with your memory or concentration, this treatment might help improve your symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 35 to 80 years old and speak Chinese.
- You have been treated with at least one chemotherapy drug (like cyclophosphamide, cisplatin, paclitaxel, or doxorubicin).
- Your memory or thinking problems started at least 3 months before you began chemo.
- You have a confirmed diagnosis of cancer (except for tumors in the brain or spine).
- You do not have other conditions that already cause memory loss, like Alzheimer's disease.
- You are not currently taking other medications that affect memory or thinking.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at cognitive (thinking and memory) changes in people with colorectal cancer who start certain chemotherapy drugs. It aims to understand how treatment affects the brain and may guide better monitoring or support during care.
This study looks at how chemotherapy may affect memory and thinking, using thinking tests and possibly brain imaging. It compares older breast cancer patients who do and do not get chemotherapy, plus a group of healthy older adults.
This study checks how breast cancer affects memory and thinking before other treatments start. It may help doctors better understand cognitive changes and who is most at risk.
This trial studies a phone or tablet brain-training program to help with “cancer-related cognitive impairment,” or thinking and memory problems that can happen during chemotherapy. If you’re newly diagnosed with certain gynecologic cancers and are receiving chemotherapy, this may help you see whether the training improves cognitive symptoms.
This pilot study tests whether the drug riluzole can help prevent the thinking and memory problems (often called 'chemobrain') that some people experience during chemotherapy. If you are about to start a chemo regimen containing an anthracycline or platinum drug, you may be able to join.
This study tests a drug called butylphthalide to see if it can help with memory and thinking problems that some people have after finishing chemotherapy. If you have had certain types of chemo and are struggling with your memory, this might be a way to find help.
Hear when a new Chemo-brain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.